Gliclazide (80mg)
Danavish Gliclazide+Metformin is a fixed-dose combination tablet containing Gliclazide (80mg) and Metformin (500mg) in modified release formulation. This belongs to the antidiabetic medication category combining a sulfonylurea with a biguanide. The medicine is classified under General schedule and is available in strip packaging of 10 tablets. GST applicable is 5% as per Indian tax regulations, with HSN code 3004 for pharmaceutical preparations.
The following medicines contain the same active ingredient (Gliclazide (80mg)) and may be offered by pharmacists as substitutes. Actual substitute selection depends on availability at your pharmacy and prescribing doctor's instructions.
Look any other medicine up the same way:
Gliclazide+Metformin combination tablets attract 5% GST in India and are classified under HSN code 3004, which covers pharmaceutical preparations for therapeutic or prophylactic uses.
Danavish Gliclazide+Metformin 80mg/500mg Tablet MR is a Schedule H medicine and requires a prescription from a registered medical practitioner. Confirm against the current Schedule H, H1 and X lists notified in the Gazette of India before dispensing.
Common brand variants may include Gluconorm-G, Diazide-M, Glimulin-M, and Glyclazide-M among others. Brand availability may vary across different pharmaceutical manufacturers in the Indian market.
Nesayo tracks your stock, flags near-expiry, and auto-orders from your distributor when you run low.
Start free →This page is informational only. Pricing and availability vary by pharmacy, location, and time. Verify current MRP on the printed package before sale. Consult a registered physician or pharmacist for medical advice. Nesayo is not a medical device and does not provide clinical decision support.